I. Bocci

The β-carboline Harmine improves the therapeutic benefit of anti-PD1 in melanoma by increasing the MHC-I-dependent antigen presentation

G. Berchem, B. Janji, M. Noman, 2022, Frontiers in Immunology.

ETV7 reduces inflammatory responses in breast cancer cells by repressing the TNFR1/NF-κB axis

S. Bicciato, M. Forcato, M. Barbareschi, 2022, bioRxiv.

Impact of hypoxic tumor microenvironment and tumor cell plasticity on the expression of immune checkpoints.

G. Berchem, B. Janji, M. Noman, 2019, Cancer letters.